Signaling Pathways Take Aim at Neurotransmitter Transporters

Michael B. Robinson^*

Departments of Pediatrics and Pharmacology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104-4318, USA.

Summary: Neurotransmitter transporters are the target of various pharmacological agents used to treat psychological or cognitive conditions, such as depression and attention-deficit disorder. In addition, some of the effects of stimulant-type drugs of abuse result from inhibition of neurotransmitter transporters. Robinson describes the intersection between neurotransmitter transporters and signaling pathways. Neurotransmitter transporters can be regulated by altering the rate of internalization and insertion into the plasma membrane to control cell surface expression or by altering the activity of the transporters within the membrane. As the mechanisms governing regulation of these transporters become elucidated, new potential therapeutic targets may be revealed, given the many processes affected by the activity of neurotransmitter transporters.

*Contact information. Telephone, 215-590-2205; fax, 215-590-3779; e-mail, robinson{at}pharm.med.upenn.edu

The editors suggest the following Related Resources on Science sites:

In Science Signaling

EDITORS' CHOICE
Neuroscience
Does D2 Determine DAT Location?

Elizabeth M. Adler (24 April 2007)
Sci. STKE 2007 (383), tw141. [DOI: 10.1126/stke.3832007tw141]
 |  Abstract »

EDITORS' CHOICE
PHARMACOLOGY
Antidepressant Activity Requires Norepinephrine

(1 June 2004)
Sci. STKE 2004 (235), tw193. [DOI: 10.1126/stke.2352004TW193]
 |  Abstract »

EDITORIAL GUIDES
Focus Issue: Brain Disease--Signaling on My Mind

Elizabeth M. Adler and Nancy R. Gough (4 November 2003)
Sci. STKE 2003 (207), eg14. [DOI: 10.1126/stke.2003.207.eg14]
 |  Full Text »  |  PDF »